Community Healthcare Trust Inc (CHCT)
Assessment summary
Investable with eyes open — watch the weaker categories.
Compare peers
Healthcare names covered in the tracker.
Price
$17.70
Yield
10.76%
P/(A)FFO
7.90x
Payout
1.17x
Occupancy
92.0%
Net debt / EBITDA
3.50x
Category scores
Six weighted categories make up the overall quality score. Each renders its own rationale once this name has been through a scoring pass.
Cash flow & dividend safety
CHCT demonstrates strong cash flow safety with AFFO per share of $0.56 and a payout ratio of approximately 60% following the 31% dividend reduction, well below the 75% threshold for a score of 5. The company is actively managing capital allocation to fund growth through acquisitions and occupancy improvements, with a $99 million pipeline yielding 9-10% returns. While current AFFO growth trajectory cannot be fully assessed from a single quarter, management's strategic pivot to rightsizing the dividend and reinvesting capital suggests positioning for future AFFO growth. The main limitation is lack of multi-year AFFO trend data to confirm the "steadily growing" criterion for a perfect 5 score.
Balance sheet
CHCT's balance sheet metrics align closely with the 5-anchor criteria. Net debt/EBITDA of 3.5x is well below the 5x threshold, indicating conservative leverage. Payout coverage of 1.18x (AFFO-based) exceeds the 4x coverage benchmark for a 5-rated balance sheet, though this reflects dividend sustainability rather than debt service coverage. The company is actively managing its capital structure by reducing its dividend by 31% to retain $25–30 million over two years for acquisitions and occupancy improvements. While the earnings release does not explicitly detail debt maturity laddering or fixed-rate composition, the moderate leverage and strong occupancy at 92% suggest a well-positioned balance sheet. The absence of specific debt structure details prevents a perfect 5 score, but the quantitative metrics and strategic capital reallocation demonstrate solid financial health above the 3-anchor range.
Operating performance
CHCT demonstrates operating performance aligned with the mid-range anchor. Occupancy stands at 92%, which is stable but in the low 90s rather than the 95%+ threshold for a score of 5. The company explicitly targets occupancy improvement to 92% as a key strategic priority, indicating current performance is at target rather than exceeding it. While specific SSNOI growth rates are not disclosed in the earnings release, rental income grew modestly from $30.1 million (Q2 2025) to $31.0 million (Q2 2026), representing roughly flat to low single-digit growth consistent with the 3-anchor description. The company is pursuing accretive acquisitions and portfolio reinvestments with 9-12% yields, suggesting management confidence in operational improvements ahead, but current quarter results show stabilization rather than strong momentum.
Portfolio & sector quality
CHCT operates in outpatient healthcare real estate, a stable but competitive sector with moderate structural tailwinds from aging demographics and healthcare consolidation. The portfolio spans 197 properties across 36 states with 4.5 million square feet, providing reasonable geographic diversification, though tenant concentration appears moderate with a notable exposure to a geriatric behavioral hospital operator across six properties currently in transition. The 92% occupancy rate is solid but not exceptional, and the company is targeting occupancy improvement as a strategic priority. Assets appear to be of average quality with a mix of modern and legacy properties; the company is actively pursuing portfolio reinvestment and capital recycling, suggesting some aging assets. The sector is stable rather than experiencing secular tailwinds, and while the company has a $99 million acquisition pipeline with 9-10% expected yields, this reflects competitive market conditions rather than supply constraints.
Management & capital allocation
CHCT demonstrates mixed capital allocation discipline. Positively, management implemented a decisive 31% dividend cut to fund accretive acquisitions (9-10% expected yields on $99 million pipeline), enhanced disclosure with expanded supplemental information including FAD metrics, and suspended ATM issuance during Q2 2026. However, the company shows dilutive share issuance history—common shares outstanding increased from 26.8 million (Q2 2025) to 28.7 million (June 2026), representing approximately 7% dilution over one year without corresponding per-share growth acceleration. The payout coverage ratio of 1.18x and AFFO payout ratio of 60% post-dividend cut suggest more disciplined capital allocation going forward, but the historical dilution pattern and lack of disclosed insider ownership information prevent a higher score.
Valuation
Mechanical valuation (D-07): current ratio 7.9 vs 15-point own history, percentile rank 0.00.
Score history
Event-anchoredIllustrative history — each point corresponds to a scoring trigger (filing, announcement, or initial coverage). At launch a name has a single point.
Sources
Sources are the exact documents used by this assessment, recorded when it ran.
Metric history
P/(A)FFOP/(A)FFO over time — 28 data points since Aug 2, 2026.
Scores are analytical opinions, not investment advice. Figures reflect the most recent data available as of the assessed date and may differ from current market values.